The invention relates to novel antimicrobial, including antibacterial and antifungal, agents and compositions based on hemin derivatives of general formula (I), and also to the production of novel hemin derivatives. The advantages of antibacterial agents based on hemin derivatives are their biocompatibility, biodegradability, high effectiveness against resistant bacteria and widespread microfungi that are harmful to humans, and freedom from toxicity and side effects.
这项发明涉及基于一般式(I)的血红素衍
生物的新型抗微
生物药物,包括抗菌和抗真菌剂以及组合物,还涉及新型血红素衍
生物的生产。基于血红素衍
生物的抗菌剂的优点在于它们具有
生物相容性、
生物降解性、对抗耐药细菌和对人类有害的广泛微真菌高效,并且不具有毒性和副作用。